Jonathan Sherman

Partner

Cassels

Office Phone:

(416) 869-5300

Direct Phone:

(416) 869-5409


  Pro - Try 1 Week Free
 

    and access,

  •     80K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     198K Transactions
  •     202K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Jonathan Sherman serves as Executive Co-Chair, is a partner in the Securities Group at Cassels and Chair of the Cannabis Group. Jonathan’s practice focuses on emerging and high-growth industries, including cannabis, technology, natural resources, beverage alcohol, gaming, blockchain, cryptocurrency and psychedelic medicines. In his role as Co-Chair of the firm’s Cannabis Group, Jonathan is at the forefront of many of the largest industry transactions in this evolving sector, providing strategic and legal advice to a range of leading industry players on complex and innovative transactions. Jonathan acts for a wide variety of domestic and international companies and investment banks. With corporate clients ranging from start-ups to multibillion-dollar businesses, Jonathan’s practice focuses on mergers and acquisitions (public and private acquisitions, business combinations, joint ventures, go-public transactions and strategic collaborations) and corporate finance transactions (public offerings, venture capital, private equity offerings and debt financing transactions). Whether strategically guiding clients through M&A, or helping emerging start-ups secure investments, Jonathan has become a trusted advisor to many. In addition, he has played a central role on several of the largest transactions completed to-date in the cannabis industry. He acts for industry-leader Canopy Growth on corporate, commercial, securities and M&A matters, including numerous M&A transactions valued at over $5 billion; a $600 million offering of senior convertible unsecured notes, a US$1.25 billion senior secured debt financing and various innovative cross-border transactions to facilitate Canopy Growth’s conditional exposure to the United States cannabis market in advance of federal legalization.

Education